World's Best Scientists 2026 revealed!
Maria Domenica Cappellini

Maria Domenica Cappellini

D-Index & Metrics

Medicine

D-Index
97
Citations
39114
World Ranking
9194
National Ranking
319

Overview

Maria Domenica Cappellini is affiliated with the University of Milan in Italy and specializes in medicine with a focus on hematology and genetics. Their research contributions span several subfields including physiology, molecular biology, and pediatrics, perinatology and child health.

The key topics addressed in their work include:

  • Hemoglobinopathies and Related Disorders
  • Iron Metabolism and Disorders
  • Blood groups and transfusion
  • Erythrocyte Function and Pathophysiology
  • Erythropoietin and Anemia Treatment
  • Lysosomal Storage Disorders Research
  • Prenatal Screening and Diagnostics

The scientist has published extensively in high-impact venues, with frequent publications in:

  • Blood
  • American Journal of Hematology
  • HemaSphere
  • Annals of Hematology
  • Internal and Emergency Medicine

Among recent research papers, key publications include:

  • "CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia", 2020, New England Journal of Medicine
  • "β-Thalassemias", 2021, New England Journal of Medicine
  • "A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia", 2020, New England Journal of Medicine
  • "2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia", 2022, HemaSphere
  • "Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia", 2024, New England Journal of Medicine

Frequent collaborators in their research include Alì Taher, Antonis Kattamis, Irene Motta, Khaled M. Musallam, and Vip Viprakasit. These coauthors have worked together on multiple publications, contributing to the development of the field.

Best Publications

  • CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

    Haydar Frangoul;David Altshuler;M. Domenica Cappellini;Yi-Shan Chen

  • Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine

    Caterina Borgna-Pignatti;Simone Rugolotto;Piero De Stefano;Huaqing Zhao

  • A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia.

    Maria Domenica Cappellini;Alan Cohen;Antonio Piga;Mohamed Bejaoui

  • Survival and complications in thalassemia.

    Caterina Borgna-Pignatti;M. D. Cappellini;P. De Stefano;G. C. Del Vecchio

  • Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT)

    Maria Domenica Cappellini;Alan Cohen;John Porter;Ali Taher

  • Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major.

    Caterina Borgna-Pignatti;Maria Domenica Cappellini;Piero De Stefano;Giovanni Carlo Del Vecchio

  • Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management

    Maria Domenica Cappellini;Josep Comin-Colet;Angel de Francisco;Axel Dignass

  • Survival and Disease Complications in Thalassemia Major

    Caterina Borgna-Pignatti;Simone Rugolotto;Piero De Stefano;Antonio Piga

  • Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: The optimal care study

    Ali T. Taher;Khaled M. Musallam;Mehran Karimi;Amal El-Beshlawy

  • Thalassemia intermedia: Revisited

    Ali Taher;Hussain Isma'eel;Maria D. Cappellini

  • Anemia in Clinical Practice—Definition and Classification: Does Hemoglobin Change With Aging?

    M. Domenica Cappellini;M. Domenica Cappellini;Irene Motta;Irene Motta

  • Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran

    Ali Taher;Hussain Isma’eel;Ghassan Mehio;Daniela Bignamini

  • Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association.

    Silvia Fargion;Alberto Piperno;Maria Domenica Cappellini;Maurizio Sampietro

  • Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel

    Emanuele Angelucci;Susanne Matthes-Martin;Donatella Baronciani;Françoise Bernaudin

  • Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia.

    M. D. Cappellini;L. Robbiolo;B. M. Bottasso;R. Coppola

  • Iron deficiency anaemia revisited

    Maria Domenica Cappellini;Khaled M. Musallam;Ali T. Taher

  • Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload.

    Antonio Piga;Renzo Galanello;Gian Luca Forni;Maria Domenica Cappellini

  • Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias.

    Maria Domenica Cappellini;John Porter;Amal El-Beshlawy;Chi Kong Li

  • Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study

    John Porter;Renzo Galanello;Giuseppe Saglio;Ellis E.J. Neufeld

  • Survival and disease complications in thalassemia major

    Caterina Borgna-Pignatti;Antonio Piga;Simone Rugolotto;Piero De Stefano

Frequent Co-Authors

John B. Porter
John B. Porter University College London
Silvia Fargion
Silvia Fargion University of Milan
Renzo Galanello
Renzo Galanello University of Cagliari
Achille Iolascon
Achille Iolascon University of Naples Federico II
Dario Consonni
Dario Consonni University of Milan
Anna Ludovica Fracanzani
Anna Ludovica Fracanzani University of Milan
Flora Peyvandi
Flora Peyvandi University of Milan
Giuliana Ferrari
Giuliana Ferrari Vita-Salute San Raffaele University
Domenico Girelli
Domenico Girelli University of Verona
John D. Phillips
John D. Phillips University of Utah

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to Medicine opens up flexible, affordable, and accelerated options for advancing your healthcare career. Prospective nurses and practitioners can build upon their qualifications without pausing their professional journey. One popular route is enrolling in dnp programs online, allowing registered nurses to earn a Doctor of Nursing Practice remotely and at their own pace.

Cost is a significant concern for most students. Choosing the cheapest dnp program can help minimize debt while still ensuring a reputable education. For those eager to enter the workforce quickly, the lpn accelerated program offers a faster route to practical nursing roles, often in under a year.

Specialization is key in today’s healthcare landscape. Pursuing pathways like an msn to pmhnp online can lead to rewarding roles in psychiatric mental health, with the convenience of a fully online curriculum. By exploring these options, students can align academic goals with evolving career demands.

Best Scientists Citing Maria Domenica Cappellini

Trending Scientists

Recently Published Articles